Characterisation of Endothelial Cells in Different Inflammatory Pathologies
Recruiting now
Conditions studied: Sepsis, Vasoplegia
In brief
The goal of this observational study is to characterise changes in gene expression in endothelial cells in patients with either sepsis or post major abdominal surgery. The main question we plan to answer is: 'What molecular pathways are differentially expressed during inflammatory pathologies?'
Key facts
- Study ID
- NCT06613256
- Run by
- Royal Surrey County Hospital NHS Foundation Trust
- People needed
- 105
- Starts
- 2024-07-16
- Expected to finish
- 2026-11-12
- Last updated by the study team
- 2024-09-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy volunteer
- Adult ≥ 18 years
- Able and willing to give consent
- Surgical patients
- Adult ≥ 18 years
- Patients admitted to RSFT for planned major surgery
- Critically ill patients
- Adult ≥ 18 years
- Emergency admission to ICU at RSFT
- Meets the sepsis 3.0 definition
You may not qualify if…
- Healthy volunteer
- Not currently a patient within the hospital
- Absence of inflammatory diseases and disorders including but not limited to arthritis, peripheral artery disease, vasculitis, diabetes, cardiovascular disease and CKD.
- Not on immunomodulatory medications, such as corticosteroids
- History of recent major trauma within the last 2 months (e.g., surgery or injury requiring hospitalisation)
- Surgical patients
- Patients with restricted liberty, prisoners or under legal protection
- Anticipated prohibitively difficult venous cannulation
- Presenting with inflammatory diseases and disorders including but not limited to arthritis, peripheral artery disease, vasculitis, sepsis, diabetes with end organ damage, cardiovascular disease and CKD
- Currently prescribed immunomodulatory medication or immunocompromised
- Received chemotherapy within 2 weeks of predicted sampling
- Receiving vasopressor support prior to surgery
- History of recent major trauma within the last 2 months (e.g., surgery or injury requiring hospitalisation)
- Critically ill patients
- Patients with restricted liberty, prisoners or under legal protection• Anticipated prohibitively difficult venous cannulation
- Presenting with inflammatory diseases and disorders including but not limited to arthritis, peripheral artery disease, vasculitis, diabetes with end organ damage, cardiovascular disease and CKD.
- Currently prescribed immunomodulatory medication or immunocompromised
- Received chemotherapy within 2 weeks of predicted sampling.
- History of recent major trauma within the last 2 months (e.g., surgery or injury requiring hospitalisation)
Where it is running
- Royal Surrey NHS Foundation Trust — Guildford, Surrey, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.